AFSCME recommends opposing executive comp proposals at both Pfizer and Johnson & Johnson.
As earnings season kicks off, the investment bank is looking for 6.9 percent revenue growth and 12 percent earnings growth.
Increased reliance on clearinghouses due to Dodd-Frank means more precautions have to be taken.
Goldman's Viniar made $18.6 million while JPMorgan Chase's Braunstein made $16.7 million.
Surging oil prices are threatening to make next week's policy meeting more contentious.
Filings stem from an October letter fired off to corporate finance executives by the Securities and Exchange Commission.
Several of the more dire predictions about healthcare reform proved to be unfounded.
Asia President Kal Patel calls China market "explosive."
Are the emerging market economies that powered the global recovery growing too fast for their own good?
Petty jealousy over Other People's Money is threatening to escalate.
However, downgrades of the company's debt are not expected.
This just in: 401(k) plan providers might not be all that impartial about the investment choices they recommend.
Is your company saving cash? ARS still a pain in the backside for CFOs Health-care reform verdict? People are cattle